Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome
What this study shows
Rapamycin-fed mice show extended lifespan with major changes in the liver transcriptome.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Mouse); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Mouse |
| Journal | PloS one |
| Year | 2014 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1371/journal.pone.0083988 · PMID 24409289 · Free full text (PMC3883653) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Rapamycin (from 4 months of age) |
| Target | mTOR |
| Model | Mouse (C57BL/6J) |
| Effect | Rapamycin increased lifespan 11-16% with major changes in the liver transcriptome |
| Dose | 14 ppm encapsulated rapamycin in food, ad libitum, starting at 4 months of age until end of life |
| Sample size | 175 mice total (40 control males, 45 Rapa males, 45 control females, 45 Rapa females) |
| Effect size | Rapamycin increased lifespan 16% in females and 11% in males (entire survival curve analysis), and significantly increased mean (14% females, 7% males) and maximum (19% females, 8% males) survival. |
| Limitations | not stated |
In the Atlas
Related topics
Open questions that cite this study
- Cited as supporting evidence for the open question Does the larger rapamycin benefit in female mice survive equal drug exposure, and is it set by hormones or by chromosomes?.
Was this page useful?
Thank you. Your answer was counted anonymously.